Pregnancies after breast cancer: Is there a real need for fertility preservation? Results from the ARTEMIS cohort of 60 young patients
Martin-Babau, J., Toudic-Emily, F., Boivin, A.-H., Burban-Provost, P., Vie, B., Etienne, P.-L., Lamezec, B., Le Fur, E., Vincent, A., Besson, D., Hardy-Bessard, A.-C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer
Thierry, Alain R, Pastor, Brice, Pisareva, Ekaterina, Ghiringhelli, Francois, Bouché, Olivier, De La Fouchardière, Christelle, Vanbockstael, Julie, Smith, Denis, François, Eric, Dos Santos, Mélanie, Botsen, Damien, Ellis, Stephen, Fonck, Marianne, André, Thierry, Guardiola, Emmanuel, Khemissa, Faiza, Linot, Benjamin, Martin-Babau, J, Rinaldi, Yves, Assenat, Eric, Clavel, Lea, Dominguez, Sophie, Gavoille, Celine, Sefrioui, David, Pezzella, Veronica, Mollevi, Caroline, Ychou, Marc, Mazard, Thibault
Published in JAMA network open (01.09.2021)
Published in JAMA network open (01.09.2021)
Get full text
Journal Article
2303 Effect of the inhibition of the Renine-Angiotensine system (RAS) as potentiator of gemcitabine in metastatic pancreatic cancer
Martin-Babau, J, Basse, V, Lucia, F, Perret, C, Laubel, A, Cheneau, C, Trouboul, F, Robaszkiewicz, M, Verveur, C, Simon, H, Metges, J.P
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort
Martin-babau, J, Robert, M, Septans, A.L, Paillard, M.J, Pivot, X, Soibinet, P, Gourmelon, C, Brunot, A, Lefeuvre-plesse, C, Korenbaum, C, Petit, T, Marquis, A, Bourgeois, H, Uwer, L, Som, M, Desclos, H, Campone, M, Campion, L, Tredan, O, Patsouris, A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)
Patsouris, A, Septans, A.L, Paillard, M.J, Pivot, X, Soibinet, P, Jovenin, N, Robert, M, Gourmelon, C, Korembaum, C, Petit, T, Martin-babau, J, Brunot, A, Lefeuvre-plesse, C, Adele, M, Bourgeois, H, Som, M, Uwer, L, Campone, M, Campion, L, Tredan, O
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
CN15 Real-life clinical and organizational evaluation of telemonitoring and assisted telemonitoring in more than 1500 cancer patients
Martin, S., Fritsch, A., Jouannaud, C., Martin-Babau, J., Mennecier, B., Slimano, F., Bordeau, A., Guéroult-Accolas, L., Delcour, B., Raymond, E., Renet, S., Sonntag, C., Morel, A., Barthelemy, P.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
433P Durvalumab and tremelimumab in combination with FOLFOX in patients with previously untreated RAS-mutated metastatic colorectal cancer: First results of efficacy at one year for phase II MEDITREME trial
Fumet, J-D., Chibaudel, B., Bennouna, J., Borg, C., Martin-Babau, J., Cohen, R., Fonck, M., Taieb, J., Thibaudin, M., Limagne, E., Blanc, J., Bertaut, A., Ghiringhelli, F.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
600TiP A randomized blinded phase II study of ompenaclid (RGX-202-01) vs placebo in combination with FOLFIRI plus bevacizumab (BEV) in patients (pts) with previously treated RAS mutated (RASmt) advanced/metastatic colorectal cancer (mCRC)
Elez Fernandez, M.E., Rosello Keranen, S., Paez, D., Jiménez Castro, J., Rivera Herrero, F., Ruiz-Casado, A., Riesco Martinez, M.C., Montagut Viladot, C., Coupez, D., Ducreux, M.P., Loly, C., Martin-Babau, J., Prenen, H., van den Eynde, M., Borg, C., Cuyle, P-J., de Haar-Holleman, A., Raimbourg, J., Bechar, N., Tabernero, J.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1447P Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study
Tougeron, D., Mineur, L., Zaanan, A., Kadi, M., Poisson Ligeza, C., Bourgeois, V., Martin-Babau, J., Fadin, A., Jestin, V., Le Brun-Ly, V., Dubreuil, O., Khemissa, F., Thimonier, E., Bouche, O., Lievre, A., Di Fiore, F., Lecomte, T., Desrame, J., Lepage, C., Hautefeuille, V.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
793TiP A phase III, randomized, open-label, multicenter study of sacituzumab tirumotecan (sac-TMT) monotherapy vs treatment of physician’s choice chemotherapy in patients with endometrial cancer who have received prior chemotherapy and immunotherapy: ENGOT-en23/GOG-3095/MK-2870-005
Lorusso, D., Mirza, M.R., Martin-Babau, J., Bologna, A., Barretina Ginesta, M.P., Marmé, F., Wampfler, J., Cibula, D., Zhu, J., Hasegawa, K., Samouëlian, V., Lee, J-Y., Casarotto, F.C., Antill, Y., Lightfoot, M., Herzog, T.J., Woodhouse, K., Cui, Y., Slomovitz, B.M., Monk, B.J.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
47P Does metastatic site influence the outcome in colorectal cancer patients treated with regorafenib? Insights from the phase II randomized study SOREGATT - PRODIGE 68 - UCGI 38
Smolenschi, C., Tanguy, M-L., Ben Abdelghani, M., Parzy, A., Tougeron, D., Bouche, O., Martin-Babau, J., Bachet, J-B., Taieb, J., Viaud, J., Khemissa Akouz, F., Fares, N., Castanie, H., Etchepare, N., Cacheux, W., Coutzac, C., Botsen, D., Mailleux, M., Ducreux, M.P., Boileve, A.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
3O PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC)
Ducreux, M.P., Ben Abdelghani, M., Tougeron, D., Bouche, O., Viaud, J., Khemissa Akouz, F., Martin-Babau, J., Bachet, J-B., Coutzac, C., Castanie, H., Taieb, J., Phelip, J.M., Fares, N., Cacheux, W., Etchepare, N., Botsen, D., Mailleux, M., Chevrot, M., Tanguy, M-L., Parzy, A.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
LBA30 Panitumumab (P) + FOLFIRINOX or mFOLFOX6 in unresectable metastatic colorectal cancer (mCRC) patients (pts) with RAS/BRAF wild-type (WT) tumor status from circulating DNA (cirDNA): First results of the randomised phase II PANIRINOX-UCGI28 study
Mazard, T., Ghiringhelli, F., Winter, A., de la Fouchardiere, C., Botsen, D., André, T., Vanbockstael, J., Dos Santos, M., Martin-Babau, J., Rinaldi, Y., Evesque, L., Ellis, S., Gavoille, C., Smith, D., Fonck, M., Sefrioui, D., Pezzella, V., Nougaret, S., Thierry, A.R., Bouche, O.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
508TiP PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC)
Ducreux, M.P., Parzy, A., Ben Abdelghani, M., Martin-Babau, J., Tougeron, D., Botsen, D., Taieb, J., Pannier, D., Khemissa, F., Viaud, J., Villing, A.L., Bouche, O., Peytier, A., Alexandre, H., Garic, F., Tanguy, M-L., Bachet, J-B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
808MO Paclitaxel with or without pazopanib in ovarian cancer patients with relapse during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study
Joly Lobbedez, F., Fabbro, M., Berton, D., Lequesne, J., Anota, A., Puszkiel, A., Floquet, A., Cancel, M., Bourgeois, H., Bengrine Lefevre, L., You, B., Pommeret, F., Lortholary, A., Spaeth, D., Martin-Babau, J., Abdeddaim, C., Kaminsky-Forrett, M-C., Petran, D., Provansal Gross, M., Brachet, P-E.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
251P_PRPregnancies after breast cancer: Is there a real need for fertility preservation? Results from the ARTEMIS cohort of 60 young patients
Martin-Babau, J, Toudic-Emily, F, Boivin, A-H, Burban-Provost, P, Vie, B, Etienne, P-L, Lamezec, B, Le Fur, E, Vincent, A, Besson, D, Hardy-Bessard, A-C
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P-086 Trastuzumab induced cardiotoxicity in Her2 positive metastatic oeso-gastric cancers
Eusen, Y., Martin-Babau, J., Verveur, C., Trouboul, F., Cheneau, C., Jestin-Le Tallec, V., Simon, H., Metges, J.-P.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article
Eribulin is safe and efficient in metastatic breast cancer in elderly patients. Results from the REPROLINE multicentric retro-prospective cohort
Martin-Babau, J., Robert, M., Seegers, V., Paillard, M-J., Pivot, X., Gourmelon, C., Uwer, L., Korenbaum, C., Petit, T., Thery, J-C., Som, M., Lefeuvre-Plesse, C., Perret, C., Simon, H., Hardy-Bessard, A-C., Desclos, H., Bourgeois, H., Campone, M., Tredan, O., Patsouris, A.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase II trial evaluating the combination of eribulin (E)+ bevacizumab (BEV) as first line chemotherapy in patients with metastatic Her2-negative breast cancer (MBC): a GINECO group study
Hardy-Bessard, A.-C., Brocard, F., Leheurteur, M., Melis, A., Dauba, J., Lortholary, A., You, B., Guardiola, E., Grenier, J., Martin-Babau, J., Meunier, J., Follana, P., Savoye, A.-M., Mercier-Blas, A., Marti, A., Despax, R., Barbier, N., Gane, N., Ardisson, P., Segura-Djezzar, C.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article